Impact of dose intensity of ponatinib on selected adverse events: Multivariate analyses from a pooled population of clinical trial patients

Title
Impact of dose intensity of ponatinib on selected adverse events: Multivariate analyses from a pooled population of clinical trial patients
Authors
Keywords
BCR-ABL1, Chronic myeloid leukemia, Dose intensity, Philadelphia chromosome, Ponatinib, Tyrosine kinase inhibitor
Journal
LEUKEMIA RESEARCH
Volume 48, Issue -, Pages 84-91
Publisher
Elsevier BV
Online
2016-07-24
DOI
10.1016/j.leukres.2016.07.007

Ask authors/readers for more resources

Reprint

Contact the author

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now